Cargando…
Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β-Secretase
Amyloidogenic pathway in Alzheimer's disease (AD) involves breakdown of APP by β-secretase followed by γ-secretase and results in formation of amyloid beta plaque. β-secretase has been a promising target for developing novel anti-Alzheimer drugs. To test different molecules for this purpose, te...
Autores principales: | Nisha, Chaluveelaveedu Murleedharan, Kumar, Ashwini, Nair, Prateek, Gupta, Nityasha, Silakari, Chitrangda, Tripathi, Timir, Kumar, Awanish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842033/ https://www.ncbi.nlm.nih.gov/pubmed/27190510 http://dx.doi.org/10.1155/2016/9258578 |
Ejemplares similares
-
Viral targets of acylguanidines
por: Gazina, Elena V., et al.
Publicado: (2012) -
Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
por: Zou, Yiquan, et al.
Publicado: (2013) -
Amino Acylguanidines as Bioinspired Catalysts for the Asymmetric Aldol Reaction
por: Jimeno, Ciril
Publicado: (2021) -
In silico ADMET, molecular docking and molecular simulation-based study of glabridin’s natural and semisynthetic derivatives as potential tyrosinase inhibitors
por: Kumari, Arti, et al.
Publicado: (2022) -
Antibacterial, Anticandidal, and Antibiofilm Potential of Fenchone: In Vitro, Molecular Docking and In Silico/ADMET Study
por: Ahmad, Wasim, et al.
Publicado: (2022)